Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
50,518,366
-
Share change
-
+1,157,871
-
Total reported value
-
$553,155,689
-
Put/Call ratio
-
169%
-
Price per share
-
$10.95
-
Number of holders
-
135
-
Value change
-
+$7,440,407
-
Number of buys
-
75
-
Number of sells
-
64
Institutional Holders of INFINITY PHARMACEUTICALS INC - COM (INFI) as of Q2 2015
As of 30 Jun 2015,
INFINITY PHARMACEUTICALS INC - COM (INFI) was held by
135 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
50,518,366 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, VANGUARD GROUP INC, ORBIMED ADVISORS LLC, STATE STREET CORP, BlackRock Fund Advisors, BB BIOTECH AG, DEERFIELD MANAGEMENT CO, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, and BlackRock Institutional Trust Company, N.A..
This page lists
135
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.